We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$25.3M
(+4.5%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$3.6M |
| 2 |
NVIDIA
NVDA
|
+$1.81M |
| 3 |
Natera
NTRA
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$1.41M |
| 5 |
SentinelOne
S
|
+$706K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.86M |
| 2 |
Microsoft
MSFT
|
+$2.82M |
| 3 |
Mastercard
MA
|
+$2.78M |
| 4 |
Comcast
CMCSA
|
+$2.56M |
| 5 |
Apple
AAPL
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35% |
| 2 | Healthcare | 14.27% |
| 3 | Consumer Discretionary | 13.55% |
| 4 | Communication Services | 11.79% |
| 5 | Financials | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medtronic
MDT
$109B
| $2.79M | 0.48% |
26,817
-1,477
| -5% | -$171K |
|
52
American Express
AXP
$227B
| $2.73M | 0.47% |
16,703
-693
| -4% | -$118K |
|
53
Booking.com
BKNG
$149B
| $2.71M | 0.46% |
28,250
-1,175
| -4% | -$111K |
|
54
CME Group
CME
$96.3B
| $2.66M | 0.46% |
11,492
-578
| -5% | -$127K |
|
55
Tradeweb Markets
TW
$21.4B
| $2.52M | 0.43% |
25,140
-1,572
| -6% | -$145K |
|
56
Merck
MRK
$322B
| $2.44M | 0.42% |
31,545
| – | – |
|
57
Align Technology
ALGN
$12.1B
| $2.41M | 0.41% |
3,674
-286
| -7% | -$184K |
|
58
Cooper Companies
COO
$14.1B
| $2.39M | 0.41% |
22,808
-1,260
| -5% | -$128K |
|
59
FIVE9
FIVN
$2.11B
| $2.38M | 0.41% |
17,319
-934
| -5% | -$138K |
|
60
Bristol-Myers Squibb
BMY
$133B
| $2.37M | 0.4% |
37,945
-1,491
| -4% | -$87.5K |
|
61
Chipotle Mexican Grill
CMG
$47.2B
| $2.35M | 0.4% |
67,200
-2,800
| -4% | -$98.6K |
|
62
Northrop Grumman
NOC
$77.1B
| $2.31M | 0.39% |
5,955
-335
| -5% | -$125K |
|
|
63
Natera
NTRA
$38.3B
| $2.25M | 0.38% |
24,079
+14,586
| +154% | +$1.51M |
|
64
Cigna
CI
$73.7B
| $2.21M | 0.38% |
9,641
-550
| -5% | -$117K |
|
65
Apollo Global Management
APO
$72.4B
| $2.17M | 0.37% |
29,894
-1,761
| -6% | -$127K |
|
66
Truist Financial
TFC
$63.3B
| $2.12M | 0.36% |
36,224
+354
| +1% | +$21.6K |
|
67
Royal Caribbean
RCL
$85.1B
| $2.01M | 0.34% |
26,181
-1,168
| -4% | -$94.9K |
|
68
PPG Industries
PPG
$24.6B
| $1.97M | 0.34% |
11,427
-664
| -5% | -$107K |
|
69
Twilio
TWLO
$30B
| $1.91M | 0.33% |
7,268
-315
| -4% | -$94.2K |
|
70
Gilead Sciences
GILD
$162B
| $1.88M | 0.32% |
25,874
-1,460
| -5% | -$101K |
|
71
Paycom
PAYC
$7.64B
| $1.83M | 0.31% |
4,403
-166
| -4% | -$78.6K |
|
72
United Parcel Service
UPS
$88.6B
| $1.77M | 0.3% |
8,277
+1,341
| +19% | +$273K |
|
73
Goldman Sachs
GS
$300B
| $1.68M | 0.29% |
4,401
-179
| -4% | -$70.9K |
|
|
74
SentinelOne
S
$6.53B
| $1.67M | 0.29% |
33,066
+12,038
| +57% | +$706K |
|
75
Las Vegas Sands
LVS
$31.7B
| $1.59M | 0.27% |
42,180
-1,881
| -4% | -$72.3K |
|
Similar funds
AG
NRCM
BAM
PFM
DMIC
LIP
CCM
HCC
Silvant Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.
- Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
- Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
- Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
- Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
- Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
- Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
- Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.
Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.